首页> 外文OA文献 >Detection and quantitation of total and allergen specific IgE in the bronchial mucosa of atopic and non-atopic asthmatics
【2h】

Detection and quantitation of total and allergen specific IgE in the bronchial mucosa of atopic and non-atopic asthmatics

机译:特应性和非特应性哮喘患者支气管黏膜中总IgE和过敏原特异性IgE的检测和定量

摘要

RationaleIgE is thought to play a role in asthma pathogenesis. We hypothesised that aeroallergen-specific IgE is detectable in the bronchial mucosa of asthmatics regardless of their conventional atopic status.MethodsAtopic (n=9) and non-atopic (n=8) asthmatics as well as non-atopic nonasthmatic controls (n=8) were recruited with informed consent according to an ethically approved protocol. Biopsies were collected at fibreoptic bronchoscopy along with venous blood serum samples. Total and allergen component specific IgE were measured using Phadia ImmunoCAP and ImmunoCAP- ISAC microarray respectively in the sera and biopsy homogenates.ResultsIgE was detectable in the serum and bronchial mucosal homogenates in all groups. The median serum total IgE concentration was significantly elevated in the atopic, but not the non-atopic asthmatics as compared with the non-atopic nonasthmatics. In contrast, the median total IgE concentration in the biopsy homogenates was significantly higher in the non-atopic, but not the atopic asthmatics compared with the controls. Allergen component-specific IgE species were not detectable by ISAC in the sera or biopsy homogenates of the non-atopic asthmatics and controls. Allergen component-specific IgE species were detectable in the sera and biopsy homogenates of the atopic asthmatics. The relative concentrations of some of these components were higher in the mucosa than in the serum.ConclusionsIt is possible to extract and characterise IgE from bronchial mucosal biopsies. IgE is detectable in the bronchial mucosa of non-atopic asthmatics but is not directed against a wide range of common aeroallergen components. The specificities and functional activities of these IgE species remain to be investigated.
机译:认为合理性在哮喘发病机理中起作用。我们假设哮喘过敏者的支气管粘膜中可检测到特定的过敏原IgE,而不论其传统的特应性状况如何。 )是根据道德规范批准的协议,并在知情同意的情况下招募。在纤维支气管镜检查中收集活检以及静脉血清样品。用Phadia ImmunoCAP和ImmunoCAP-ISAC微阵列分别测量血清和活检组织匀浆中的总和过敏原成分特异性IgE。结果在所有组的血清和支气管粘膜匀浆中均可检测到IgE。与非异位非哮喘患者相比,异位性哮喘患者中血清总IgE浓度显着升高,但非异位哮喘患者未升高。相反,非特应性哮喘患者的活检匀浆中的总IgE浓度中位数明显高于对照组。 ISAC在非特应性哮喘患者和对照的血清或活检匀浆中无法检测到过敏原成分特异性IgE物种。在特应性哮喘患者的血清和活检匀浆中可检测到过敏原成分特异性的IgE物种。这些成分中某些成分的相对浓度在粘膜中比在血清中高。结论从支气管黏膜活检中提取和鉴定IgE是可能的。在非特应性哮喘的支气管粘膜中可检测到IgE,但不能针对多种常见的气敏原成分。这些IgE物种的特异性和功能活性仍有待研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号